Sign in
4

Changes in Ownership

Elicio Therapeutics, Inc. Filed Acc 0001796436-26-000002

Options or other derivatives

  • CEO, President and Director acquired 186,944 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Connelly Robert · CEO, President and Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-16 Grant or award : show line 1 in the form Stock Option (Right to Buy) +186,944 186,944 D
Loading xslF345X06/wk-form4_1784319208.xml…